Assignee
PATHEON SOFTGELS INC
US·32 granted patents·5 pending applications·59 citations·filing 2014–2024
Top patents by PatentIndex Score
37 records- 0193US11872307B2Liquisoft capsulesPATHEON SOFTGELS INC·Filed 2022·Granted Jan 16, 2024·2 cites·11 claims
- 0293US10478429B2Abuse deterrent dosage formsPATHEON SOFTGELS INC·Filed 2017·Granted Nov 19, 2019·6 cites·18 claims
- 0391US10555901B2Liquisoft capsulesPATHEON SOFTGELS INC·Filed 2017·Granted Feb 11, 2020·5 cites·16 claims
- 0490US10357467B2All-natural enteric soft capsulesPATHEON SOFTGELS INC·Filed 2018·Granted Jul 23, 2019·7 cites·6 claims
- 0590US9867779B2Liquisoft capsulesPATHEON SOFTGELS INC·Filed 2016·Granted Jan 16, 2018·6 cites·9 claims
- 0689US2024342123A1Liquid dosage forms of sodium naproxenPATHEON SOFTGELS INC·Filed 2024·Application pending·0 cites
- 0788US10182993B2Compositions for colonic delivery of drugsPATHEON SOFTGELS INC·Filed 2016·Granted Jan 22, 2019·4 cites·4 claims
- 0886US9861586B2Chewable soft capsulesPATHEON SOFTGELS INC·Filed 2017·Granted Jan 9, 2018·3 cites·18 claims
- 0985US9980916B2Non-gelatin enteric soft capsulesPATHEON SOFTGELS INC·Filed 2014·Granted May 29, 2018·5 cites·1 claims
- 1084US12296043B2Liquisoft capsulesPATHEON SOFTGELS INC·Filed 2023·Granted May 13, 2025·0 cites·9 claims
- 1184US10342763B2Chewable soft capsulesPATHEON SOFTGELS INC·Filed 2017·Granted Jul 9, 2019·2 cites·18 claims
- 1284US9895332B2Enteric soft capsules comprising polyunsaturated fatty acidsPATHEON SOFTGELS INC·Filed 2014·Granted Feb 20, 2018·3 cites·15 claims
- 1384US9895333B2Enhanced bioavailability of polyunsaturated fatty acidsPATHEON SOFTGELS INC·Filed 2015·Granted Feb 20, 2018·2 cites·13 claims
- 1484US9775814B2Enteric soft capsule compositionsPATHEON SOFTGELS INC·Filed 2015·Granted Oct 3, 2017·5 cites·22 claims
- 1582US10182989B2Non-gelatin enteric soft capsulesPATHEON SOFTGELS INC·Filed 2018·Granted Jan 22, 2019·2 cites·8 claims
- 1682US9782374B2All-natural enteric soft capsulesPATHEON SOFTGELS INC·Filed 2017·Granted Oct 10, 2017·1 cites·19 claims
- 1781US10182991B2Silk-based capsulesPATHEON SOFTGELS INC·Filed 2018·Granted Jan 22, 2019·1 cites·5 claims
- 1880US10195211B2Soft lozenge compositionsPATHEON SOFTGELS INC·Filed 2017·Granted Feb 5, 2019·1 cites·20 claims
- 1980US10188662B2Soft lozenge compositionsPATHEON SOFTGELS INC·Filed 2017·Granted Jan 29, 2019·1 cites·20 claims
- 2079US10335405B1Non-burst releasing pharmaceutical compositionPATHEON SOFTGELS INC·Filed 2017·Granted Jul 2, 2019·1 cites·13 claims
- 2179US2021338616A1Liquid dosage forms of sodium naproxenPATHEON SOFTGELS INC·Filed 2021·Application pending·0 cites
- 2276US11090280B2Liquid dosage forms of sodium naproxenPATHEON SOFTGELS INC·Filed 2018·Granted Aug 17, 2021·0 cites·22 claims
- 2375US10226432B2Enteric soft capsule compositionsPATHEON SOFTGELS INC·Filed 2017·Granted Mar 12, 2019·1 cites·20 claims
- 2475US2020121595A1Liquisoft capsulesPATHEON SOFTGELS INC·Filed 2019·Application pending·0 cites
- 2574US10022344B2Liquid dosage forms of sodium naproxenPATHEON SOFTGELS INC·Filed 2017·Granted Jul 17, 2018·0 cites·20 claims
- 2673US10028925B2Liquid dosage forms of sodium naproxenPATHEON SOFTGELS INC·Filed 2017·Granted Jul 24, 2018·0 cites·23 claims
- 2772US10182992B2Abuse-deterrent controlled release formulationsPATHEON SOFTGELS INC·Filed 2015·Granted Jan 22, 2019·1 cites·4 claims
- 2870US10182990B2Gastric reflux resistant dosage formsPATHEON SOFTGELS INC·Filed 2017·Granted Jan 22, 2019·0 cites·8 claims
- 2965US10188623B2Enhanced bioavailability of polyunsaturated fatty acidsPATHEON SOFTGELS INC·Filed 2018·Granted Jan 29, 2019·0 cites·20 claims
- 3065US9987240B2All-natural enteric soft capsulesPATHEON SOFTGELS INC·Filed 2017·Granted Jun 5, 2018·0 cites·19 claims
- 3163US10188624B2Enteric soft capsules comprising polyunsaturated fatty acidsPATHEON SOFTGELS INC·Filed 2018·Granted Jan 29, 2019·0 cites·19 claims
- 3263US9968561B2Silk-based capsulesPATHEON SOFTGELS INC·Filed 2014·Granted May 15, 2018·0 cites·6 claims
- 3360US2020368169A1Abuse-deterrent compositionsPATHEON SOFTGELS INC·Filed 2020·Application pending·0 cites
- 3458US10772842B2Abuse-deterrent opioidsPATHEON SOFTGELS INC·Filed 2015·Granted Sep 15, 2020·0 cites·17 claims
- 3556US10772841B2Opioid abuse-deterrent controlled release formulationsPATHEON SOFTGELS INC·Filed 2015·Granted Sep 15, 2020·0 cites·19 claims
- 3655US10335375B2Anti-overingestion abuse deterrent compositionsPATHEON SOFTGELS INC·Filed 2018·Granted Jul 2, 2019·0 cites·20 claims
- 3754US2018008548A1Controlled release preparationsPATHEON SOFTGELS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →